The outlook of companies tied to Sildenafil's past presents a complex investment picture . While the initial surge generated substantial gains, generic copies have significantly impacted revenue. Investing in connected pharmaceutical companies now requires a thorough assessment of patent protection , evolving patient trends , and the prospect for i